The enhanced contractile ability of lesional SSc fibroblasts was suppressed by blocking HSPG biosynthesis, mitogen-activated protein kinase kinase (MEK) or antagonising transforming growth factor (TGF)β receptor type I (activin-linked kinase 5 (ALK5)) [7,10]. Here, SDC2 is linked to systemic sclerosis.